By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019


SEARCH JOBS
Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at www.crownbio.com.


Key Statistics


Email: apandey@crownbio.com
Ownership: Private

Web Site: Crown Bioscience
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Oncology





Company News
Crown Bioscience Enhances Digital Connectivity With The Release Of OncoExpress Technology Platform. 2/17/2017 11:24:29 AM
Crown Bioscience Announces Expansion Of Life Science Division 1/26/2017 11:08:16 AM
Crown Bioscience Release: Company Announces Expansion Of Therapeutic Expertise Into Inflammation 1/24/2017 12:03:03 PM
Crown Bioscience Release: Company Expands US Capacity For Cardiovascular & Metabolic Disease Research; Partners With New Iberia Research Center Of Louisiana 1/12/2017 6:40:55 AM
Crown Bioscience Sets Up New U.S. Pharma Subsidiary and Creates Jobs With $70K Salaries 12/29/2016 8:04:20 AM
Crown Bioscience Announces Further Enhancement Of Its Technology Platform With New MuBase Models And Features 10/13/2016 9:03:29 AM
Crown Bioscience Introduces New In Vivo Platforms For Renal Research 10/4/2016 9:36:17 AM
Crown Bioscience Launches New Interactive Feature for XenoBase In Vitro Models 9/22/2016 9:06:57 AM
Crown Bioscience Develops Innovative NAFLD Model 9/15/2016 11:47:38 AM
Crown Bioscience Launches New Translational Platforms For Metabolic Disease At Munich Diabetes Conference 9/6/2016 1:19:53 PM
12345678
//-->